表紙
市場調査レポート

米国の病院・血液銀行・公立/民間試験所・開業医向け肝炎診断市場:10種類の免疫診断・核酸増幅検査(NAT)処置に関するサプライヤーの市場シェア・売上高の予測

2016-2020 U.S. Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

発行 Venture Planning Group 商品コード 273959
出版日 ページ情報 英文 241 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。

Local License: 同一事業所内

Back to Top
米国の病院・血液銀行・公立/民間試験所・開業医向け肝炎診断市場:10種類の免疫診断・核酸増幅検査(NAT)処置に関するサプライヤーの市場シェア・売上高の予測 2016-2020 U.S. Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
出版日: ページ情報: 英文 241 Pages
概要

当レポートでは、米国の各種医療機関(病院・血液銀行(Blood Banks)・公立/民間試験所・開業医など)向けの肝炎検査の関連市場について分析し、疾患の概要や治療法、技術開発・活用の最新状況、市場動向の見通し(今後5年間分)、主要サプライヤーの市場シェア、今後の市場機会と課題、主要企業のプロファイルと市場戦略といった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界の市場・技術の概要

  • 背景
  • A型肝炎
  • B型肝炎
  • C型肝炎
  • D型肝炎
  • E型肝炎
  • G型肝炎
  • 代表的な解析装置のレビュー(全8社分)
  • 新規の診断技術
    • 分子診断
    • モノクローナル抗体
    • 免疫学的検定
    • 差分光散乱
    • 情報技術(IT)
    • 人工知能
    • リポソーム
    • フローサイトメトリ
    • クロマトグラフィ
    • 画像診断
    • ゲル微液滴
    • その他

米国市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者の主な種類
    • 市場の細分化

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業分析

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac/PE
  • 和光純薬工業

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPID18243

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, Hbe Ag, and ALT/SGPT tests performed in the following markets:

     - Hospitals                                                                              
     - Commercial/Private Labs
     - Blood Banks
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 241 pages and 14 tables

Table of Contents

I. Introduction

II. Hepatitis Worldwide Market and Technology Overview

  • A. Background
  • B. Hepatitis A
  • C. Hepatitis B
  • D. Hepatitis C
    • Classification
    • Transmission of Infection
    • Occupational Hazards
    • Acute Hepatitis
    • Diagnosis of Acute Infection
    • Chronic Hepatitis
    • HCV and Other Chronic Liver Diseases
    • Alcoholic Liver Disease
    • Hepatitis B Coinfection
    • Cirrhosis and Hepatocellular Carcinoma
    • Diagnostic Tests
    • Possible Indications for HCV RNA Testing
    • Conclusions and Future Direction
  • E. Hepatitis D
    • Historical Perspective
    • Epidemiology
    • HBV-HDV "Coinfection" vs. "Superinfection"
    • Methods of Detecting HDV
    • Prevention
  • F. Hepatitis E
    • Background
    • Prevalence of the Disease
    • Diagnostic Tests
    • Epidemiologic Serosurveys
    • Serologic Cross-Reactivity
  • G. Hepatitis G
    • Vaccines and Drugs
  • H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
    • I. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

III. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

X. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

XI. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

XII. Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing Hepatitis Tests
  • U.S.A
  • HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A
  • HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBs Ag Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBc Ag Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBe Ag Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Back to Top